Cosgrove: We Will Not Have Price Controls on Drug Prices

The video discusses the complexities of pharmaceutical pricing, highlighting political influences, economic impacts, and the challenges Congress faces in addressing rising drug costs. It explores the role of the FDA, the arguments made by pharmaceutical companies regarding research costs, and the unique advertising practices in the U.S. and New Zealand. The need for transparency in costs and advertising budgets is emphasized as a potential solution.

What are the implications of pharmaceutical advertising in the United States?

What potential solutions could be considered to address the rising costs of pharmaceuticals?